Rapid healthcare reforms are paving the way for affordable access to medicines, but your commercial model is now outdated. The future of life-saving treatments reaching patients is under threat.
The race is on to adapt. How quickly you can create, demonstrate and scale patient value to competing stakeholders will determine whether future scientific innovation will succeed.
We must adapt to evolving payer needs, empower HCPs with crucial insights, bridge regulatory gaps and co-create with patients. Only then will we achieve exceptional outcomes and prove to be a trusted ally. Those afraid to accelerate will be left behind.
Reuters Events: Pharma USA 2024 is where senior pharma executives from Commercial, Marketing, Medical Affairs, RWE, Market Access, Patient Engagement, as well as key stakeholders, will come together to map out how they can deliver value to overcome the challenges that threaten the future viability of innovation.
Join over 1,200 of North America’s pharma pioneers, leading solutions providers, and patient advocates to sharpen short-term strategy and unite for a long-term future to exceed stakeholder desires across the value chain.